The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 15, 2022

Filed:

Mar. 02, 2022
Applicant:

Beta Bionics, Inc., Irvine, CA (US);

Inventors:

Himanshu Patel, Rancho Santa Margarita, CA (US);

Justin P. Brown, Tustin, CA (US);

Assignee:

Beta Bionics, Inc., Concord, MA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G08B 19/00 (2006.01); A61M 5/168 (2006.01); A61M 5/172 (2006.01); G06F 3/041 (2006.01); A61M 5/142 (2006.01); G06F 3/04883 (2022.01); G06F 3/16 (2006.01);
U.S. Cl.
CPC ...
A61M 5/16831 (2013.01); A61M 5/14244 (2013.01); A61M 5/16877 (2013.01); A61M 5/1723 (2013.01); G06F 3/04166 (2019.05); G06F 3/04883 (2013.01); G06F 3/16 (2013.01); A61M 2005/14208 (2013.01); A61M 2005/16863 (2013.01); A61M 2205/18 (2013.01); A61M 2205/3331 (2013.01); A61M 2205/502 (2013.01); A61M 2205/8212 (2013.01); A61M 2230/201 (2013.01); A61M 2230/63 (2013.01); G06F 2203/04808 (2013.01);
Abstract

Ambulatory medicament devices that provide therapy to a subject, such as blood glucose control, are disclosed. Disclosed systems and methods can implement one or more features that improve the user experience, by modifying delivery of therapy to a subject after determining that a possible occlusion exists in a medicament delivery system, monitoring the status of an ambulatory medical device and the health condition of a subject that receives therapy from the ambulatory medical device and annunciating alarm condition when necessary, selectively muting alarm annunciations while a Do Not Disturb mode is activated, implementing various power saving modes to save power, controlling operation of the device and medicament delivery based on the user gesture controls, and controlling medicament delivery based on a condition of the ambulatory medicament device.


Find Patent Forward Citations

Loading…